682803-14-1 Usage
Uses
Used in Pharmaceutical Research and Development:
2-AMINOMETHYL-3-(4-METHOXY-PHENYL)-PROPIONIC ACID is used as a potential drug candidate for its ability to modulate certain biological processes, making it a valuable asset in the discovery and development of new medications.
Used in Anti-inflammatory Applications:
In the medical field, 2-AMINOMETHYL-3-(4-METHOXY-PHENYL)-PROPIONIC ACID is used as an agent with potential anti-inflammatory properties, which can be beneficial in the treatment of various inflammation-related conditions.
Used in Analgesic Applications:
2-AMINOMETHYL-3-(4-METHOXY-PHENYL)-PROPIONIC ACID is also used as an analgesic agent, indicating its potential effectiveness in managing pain and providing relief for individuals suffering from pain-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 682803-14-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,2,8,0 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 682803-14:
(8*6)+(7*8)+(6*2)+(5*8)+(4*0)+(3*3)+(2*1)+(1*4)=171
171 % 10 = 1
So 682803-14-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO3/c1-15-10-4-2-8(3-5-10)6-9(7-12)11(13)14/h2-5,9H,6-7,12H2,1H3,(H,13,14)
682803-14-1Relevant articles and documents
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
Zhu, Chendan,Mandrelli, Francesca,Zhou, Hui,Maji, Rajat,List, Benjamin
supporting information, p. 3312 - 3317 (2021/04/07)
We report here a scalable, catalytic one-pot approach to enantiopure and unmodified β2-amino acids. A newly developed confined imidodiphosphorimidate (IDPi) catalyzes a broadly applicable reaction of diverse bis-silyl ketene acetals with a silylated aminomethyl ether, followed by hydrolytic workup, to give free β2-amino acids in high yields, purity, and enantioselectivity. Importantly, both aromatic and aliphatic β2-amino acids can be obtained using this method. Mechanistic studies are consistent with the aminomethylation to proceed via silylium-based asymmetric counteranion-directed catalysis (Si-ACDC) and a transition state to explain the enantioselectivity is suggested on the basis of density functional theory calculation.